Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

February 25, 2021
Review
Open Access

Alternative splicing and cancer: a systematic review.

Signal Transduction and Targeted Therapy
Yuanjiao ZhangYe Yang
February 23, 2021
Preprint
Open Access

Epitranscriptomic addition of m6A regulates HIV-1 RNA stability and alternative splicing

BioRxiv : the Preprint Server for Biology
K. TsaiBryan R. Cullen
February 24, 2021

Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant.

European Journal of Human Genetics : EJHG
Zarina YelskayaLiying Zhang
February 24, 2021

Translatomic profiling reveals novel self-restricting virus-host interactions during HBV infection.

Journal of Hepatology
Shilin YuanRonggui Hu
February 23, 2021
Preprint
Open Access

Development of alternative splicing signature in lung squamous cell carcinoma

ResearchSquare
Jia-qing YanGuo-hui Li
February 23, 2021
Preprint
Open Access

Loss of Muscleblind Splicing Factor Shortens C. elegans Lifespan by Reducing the Activity of p38 MAPK/PMK-1 and Transcription Factors ATF-7 and Nrf/SKN-1

BioRxiv : the Preprint Server for Biology
O. J. MatilainenSusana Garcia
February 22, 2021
Open Access

Highly sensitive screening of antisense sequences for different types of DMD mutations in patients' urine-derived cells.

Journal of the Neurological Sciences
Hotake TakizawaYoshitsugu Aoki
February 22, 2021

A novel splicing variant in DNAH8 causes asthenozoospermia.

Journal of Assisted Reproduction and Genetics
Zhou ZhouQing Sang
February 23, 2021
Open Access

Engineering highly efficient backsplicing and translation of synthetic circRNAs.

Molecular Therapy. Nucleic Acids
Rita M MeganckAravind Asokan
February 23, 2021
Open Access

Roles of circRNAs on tumor autophagy.

Molecular Therapy. Nucleic Acids
Wenming CuiZhenqiang Sun
February 23, 2021

Integrative analyses of transcriptome data reveal the mechanisms of post-transcriptional regulation.

Briefings in Functional Genomics
Jinkai Wang
February 23, 2021
Open Access

Evidence for the loss and recovery of SLAMF9 during human evolution: implications on Dollo's law.

Immunogenetics
Maegan K MurphyTimothy J Wilson
February 23, 2021

Herboxidiene Features That Mediate Conformation-Dependent SF3B1 Interactions to Inhibit Splicing.

ACS Chemical Biology
Adriana Gamboa LopezMelissa S Jurica

Sign up to follow this feed and discover related papers.

Related Feeds

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

© 2021 Meta ULC. All rights reserved
/feed-previews/alternative-splicing/74162fec-4777-4430-b61a-12f563c8cd7c